Human Gene NFKB2 (ENST00000661543.1_8) from GENCODE V47lift37
  Description: nuclear factor kappa B subunit 2, transcript variant 5 (from RefSeq NM_001322934.2)
Gencode Transcript: ENST00000661543.1_8
Gencode Gene: ENSG00000077150.21_17
Transcript (Including UTRs)
   Position: hg19 chr10:104,155,462-104,162,281 Size: 6,820 Total Exon Count: 23 Strand: +
Coding Region
   Position: hg19 chr10:104,155,717-104,162,133 Size: 6,417 Coding Exon Count: 22 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr10:104,155,462-104,162,281)mRNA (may differ from genome)Protein (900 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: NFKB2_HUMAN
DESCRIPTION: RecName: Full=Nuclear factor NF-kappa-B p100 subunit; AltName: Full=DNA-binding factor KBF2; AltName: Full=H2TF1; AltName: Full=Lymphocyte translocation chromosome 10 protein; AltName: Full=Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; AltName: Full=Oncogene Lyt-10; Short=Lyt10; Contains: RecName: Full=Nuclear factor NF-kappa-B p52 subunit;
FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14- activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65.
SUBUNIT: Component of the NF-kappa-B RelB-p52 complex. Homodimer; component of the NF-kappa-B p52-p52 complex. Component of the NF- kappa-B p65-p52 complex. Component of the NF-kappa-B p52-c-Rel complex. NFKB2/p52 interacts with NFKBIE. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Directly interacts with MEN1.
SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).
DOMAIN: The C-terminus of p100 might be involved in cytoplasmic retention, inhibition of DNA-binding by p52 homodimers, and/or transcription activation (By similarity).
DOMAIN: The glycine-rich region (GRR) appears to be a critical element in the generation of p52.
PTM: While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p52 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.
PTM: Subsequent to MAP3K14-dependent serine phosphorylation, p100 polyubiquitination occurs then triggering its proteasome-dependent processing.
PTM: Constitutive processing is tightly suppressed by its C- terminal processing inhibitory domain, named PID, which contains the death domain.
DISEASE: Note=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.
DISEASE: Note=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which encodes for a truncated 80 kDa protein (p80HT).
DISEASE: Note=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.
SIMILARITY: Contains 7 ANK repeats.
SIMILARITY: Contains 1 death domain.
SIMILARITY: Contains 1 RHD (Rel-like) domain.
SEQUENCE CAUTION: Sequence=CAA43715.1; Type=Frameshift; Positions=456, 458, 470, 900;
WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/NFKB2ID362.html";
WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/nfkb2/";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: NFKB2
Diseases sorted by gene-association score: immunodeficiency, common variable, 10* (1279), nfkb2-related common variable immune deficiency* (500), immunodeficiency, common variable, 1* (283), icos-related common variable immune deficiency* (283), common variable immunodeficiency* (148), b cell deficiency (10), lymphoma (7), hodgkin lymphoma (4)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -58.20164-0.355 Picture PostScript Text
3' UTR -35.79148-0.242 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR002110 - Ankyrin_rpt
IPR020683 - Ankyrin_rpt-contain_dom
IPR000488 - Death
IPR011029 - DEATH-like
IPR013783 - Ig-like_fold
IPR014756 - Ig_E-set
IPR002909 - IPT_TIG_rcpt
IPR000451 - NF_Rel_dor
IPR008967 - p53-like_TF_DNA-bd
IPR011539 - RHD

Pfam Domains:
PF00023 - Ankyrin repeat
PF00531 - Death domain
PF00554 - Rel homology DNA-binding domain
PF12796 - Ankyrin repeats (3 copies)
PF13606 - Ankyrin repeat
PF16179 - Rel homology dimerisation domain

SCOP Domains:
140860 - Pseudo ankyrin repeat-like
47986 - DEATH domain
81296 - E set domains
49417 - p53-like transcription factors
69618 - HemD-like
48403 - Ankyrin repeat

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1A3Q - X-ray MuPIT 2D96 - NMR MuPIT 3DO7 - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q00653
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000978 RNA polymerase II core promoter proximal region sequence-specific DNA binding
GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding
GO:0001077 transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
GO:0003677 DNA binding
GO:0003682 chromatin binding
GO:0003700 transcription factor activity, sequence-specific DNA binding
GO:0003713 transcription coactivator activity
GO:0005515 protein binding

Biological Process:
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0002268 follicular dendritic cell differentiation
GO:0002467 germinal center formation
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006366 transcription from RNA polymerase II promoter
GO:0006954 inflammatory response
GO:0007165 signal transduction
GO:0007249 I-kappaB kinase/NF-kappaB signaling
GO:0007568 aging
GO:0030198 extracellular matrix organization
GO:0032481 positive regulation of type I interferon production
GO:0032496 response to lipopolysaccharide
GO:0034097 response to cytokine
GO:0038061 NIK/NF-kappaB signaling
GO:0045087 innate immune response
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0048511 rhythmic process
GO:0048536 spleen development
GO:0051092 positive regulation of NF-kappaB transcription factor activity

Cellular Component:
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0033257 Bcl3/NF-kappaB2 complex


-  Descriptions from all associated GenBank mRNAs
  LF211354 - JP 2014500723-A/18857: Polycomb-Associated Non-Coding RNAs.
BC002844 - Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100), mRNA (cDNA clone MGC:3685 IMAGE:3634575), complete cds.
S76638 - p50-NF-kappa B homolog [human, peripheral blood T cells, mRNA, 3113 nt].
LF213820 - JP 2014500723-A/21323: Polycomb-Associated Non-Coding RNAs.
X61499 - H.sapiens mRNA for NF-kB subunit.
X61498 - H.sapiens mRNA for NF-kB subunit.
AK292654 - Homo sapiens cDNA FLJ75135 complete cds, highly similar to Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100), mRNA.
JD401119 - Sequence 382143 from Patent EP1572962.
JD508273 - Sequence 489297 from Patent EP1572962.
AB384801 - Synthetic construct DNA, clone: pF1KB3411, Homo sapiens NFKB2 gene for nuclear factor NF-kappa-B p100 subunit, complete cds, without stop codon, in Flexi system.
U09609 - Homo sapiens p80HT (NKFB2) mRNA, complete cds.
KT935449 - Homo sapiens nuclear factor NF-kappa-B p100 subunit (NFKB2) mRNA, complete cds.
BT009769 - Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) mRNA, complete cds.
LF345853 - JP 2014500723-A/153356: Polycomb-Associated Non-Coding RNAs.
LF345855 - JP 2014500723-A/153358: Polycomb-Associated Non-Coding RNAs.
AK098415 - Homo sapiens cDNA FLJ25549 fis, clone JTH01566, highly similar to NUCLEAR FACTOR NF-KAPPA-B P100 SUBUNIT.
LF345856 - JP 2014500723-A/153359: Polycomb-Associated Non-Coding RNAs.
LF345857 - JP 2014500723-A/153360: Polycomb-Associated Non-Coding RNAs.
LF345858 - JP 2014500723-A/153361: Polycomb-Associated Non-Coding RNAs.
JD125735 - Sequence 106759 from Patent EP1572962.
LF345859 - JP 2014500723-A/153362: Polycomb-Associated Non-Coding RNAs.
LF345860 - JP 2014500723-A/153363: Polycomb-Associated Non-Coding RNAs.
LF345861 - JP 2014500723-A/153364: Polycomb-Associated Non-Coding RNAs.
MA581430 - JP 2018138019-A/153356: Polycomb-Associated Non-Coding RNAs.
MA581432 - JP 2018138019-A/153358: Polycomb-Associated Non-Coding RNAs.
MA581433 - JP 2018138019-A/153359: Polycomb-Associated Non-Coding RNAs.
MA581434 - JP 2018138019-A/153360: Polycomb-Associated Non-Coding RNAs.
MA581435 - JP 2018138019-A/153361: Polycomb-Associated Non-Coding RNAs.
MA581436 - JP 2018138019-A/153362: Polycomb-Associated Non-Coding RNAs.
MA581437 - JP 2018138019-A/153363: Polycomb-Associated Non-Coding RNAs.
MA581438 - JP 2018138019-A/153364: Polycomb-Associated Non-Coding RNAs.
MA446931 - JP 2018138019-A/18857: Polycomb-Associated Non-Coding RNAs.
MA449397 - JP 2018138019-A/21323: Polycomb-Associated Non-Coding RNAs.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q00653 (Reactome details) participates in the following event(s):

R-HSA-5607720 p100:RELB binds active NIK:p-IKKA dimer
R-HSA-5607741 p52:RELB translocates from cytosol to nucleus
R-HSA-168166 NFkB complex is transported from cytosol to nucleus
R-HSA-168140 Phospho-IKK Complex phosphorylates IkB within the IkB:NFkB Complex
R-HSA-8865237 SETD6 methylates RELA in the NFkB complex
R-HSA-5607726 Active NIK:p-S176,180-IKKA dimer phosphorylates p100:RELB
R-HSA-5607723 SCF-beta-TRCP binds p-7S-p100 in active NIK:p-S176,180-IKKA dimer:p-7S-p100:RELB
R-HSA-5607761 Dectin-1 mediated noncanonical NF-kB signaling
R-HSA-5676590 NIK-->noncanonical NF-kB signaling
R-HSA-445989 TAK1 activates NFkB by phosphorylation and activation of IKKs complex
R-HSA-933542 TRAF6 mediated NF-kB activation
R-HSA-1810476 RIP-mediated NFkB activation via ZBP1
R-HSA-3134963 DEx/H-box helicases activate type I IFN and inflammatory cytokines production
R-HSA-3214841 PKMTs methylate histone lysines
R-HSA-5607764 CLEC7A (Dectin-1) signaling
R-HSA-5668541 TNFR2 non-canonical NF-kB pathway
R-HSA-5603029 IkBA variant leads to EDA-ID
R-HSA-166058 MyD88:Mal cascade initiated on plasma membrane
R-HSA-168164 Toll Like Receptor 3 (TLR3) Cascade
R-HSA-937061 TRIF(TICAM1)-mediated TLR4 signaling
R-HSA-975138 TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
R-HSA-975871 MyD88 cascade initiated on plasma membrane
R-HSA-9020702 Interleukin-1 signaling
R-HSA-168928 DDX58/IFIH1-mediated induction of interferon-alpha/beta
R-HSA-1606322 ZBP1(DAI) mediated induction of type I IFNs
R-HSA-1834949 Cytosolic sensors of pathogen-associated DNA
R-HSA-3247509 Chromatin modifying enzymes
R-HSA-5621481 C-type lectin receptors (CLRs)
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-5602358 Diseases associated with the TLR signaling cascade
R-HSA-166016 Toll Like Receptor 4 (TLR4) Cascade
R-HSA-168179 Toll Like Receptor TLR1:TLR2 Cascade
R-HSA-168188 Toll Like Receptor TLR6:TLR2 Cascade
R-HSA-168898 Toll-Like Receptors Cascades
R-HSA-166166 MyD88-independent TLR4 cascade
R-HSA-975155 MyD88 dependent cascade initiated on endosome
R-HSA-168142 Toll Like Receptor 10 (TLR10) Cascade
R-HSA-168176 Toll Like Receptor 5 (TLR5) Cascade
R-HSA-446652 Interleukin-1 family signaling
R-HSA-168249 Innate Immune System
R-HSA-4839726 Chromatin organization
R-HSA-168256 Immune System
R-HSA-5260271 Diseases of Immune System
R-HSA-181438 Toll Like Receptor 2 (TLR2) Cascade
R-HSA-168138 Toll Like Receptor 9 (TLR9) Cascade
R-HSA-168181 Toll Like Receptor 7/8 (TLR7/8) Cascade
R-HSA-449147 Signaling by Interleukins
R-HSA-1643685 Disease

-  Other Names for This Gene
  Alternate Gene Symbols: A8K9D9, D3DR83, LYT10, NFKB2_HUMAN, NM_001322934, Q00653, Q04860, Q9BU75, Q9H471, Q9H472, uc329hlz.1, uc329hlz.2
UCSC ID: ENST00000661543.1_8
RefSeq Accession: NM_001322934.2
Protein: Q00653 (aka NFKB2_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.